Literature DB >> 23321797

Superselective neck dissection: rationale, indications, and results.

Carlos Suárez1, Juan P Rodrigo, K Thomas Robbins, Vinidh Paleri, Carl E Silver, Alessandra Rinaldo, Jesus E Medina, Marc Hamoir, Alvaro Sanabria, Vanni Mondin, Robert P Takes, Alfio Ferlito.   

Abstract

It has been established that an appropriately indicated selective neck dissection can achieve the same oncologic results as more extensive dissections. An even more modified selective neck dissection, termed superselective neck dissection, involves the compartmental removal of the fibrofatty tissue contents within the defined boundaries of two or fewer contiguous neck levels. Evidence from retrospective studies suggests that superselective neck dissection (SSND) is oncologically sound for two indications: elective treatment of the clinically N0 neck and salvage treatment of persistent lymph node disease after chemoradiotherapy. While there is broader support for the former scenario, evidence that SSND may constitute optimal treatment in the latter is in conformity with the trend toward developing surgical techniques that provide better functional outcomes without compromising efficacy.

Entities:  

Mesh:

Year:  2013        PMID: 23321797     DOI: 10.1007/s00405-012-2344-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  47 in total

1.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery.

Authors:  K Thomas Robbins; Garry Clayman; Paul A Levine; Jesus Medina; Roy Sessions; Ashok Shaha; Peter Som; Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

2.  Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer.

Authors:  K Thomas Robbins; Muthuswamy Dhiwakar; Francisco Vieira; Krishna Rao; James Malone
Journal:  Oral Oncol       Date:  2012-07-15       Impact factor: 5.337

3.  Supraomohyoid neck dissection: rationale, indications, and surgical technique.

Authors:  J E Medina; R M Byers
Journal:  Head Neck       Date:  1989 Mar-Apr       Impact factor: 3.147

4.  End results of a prospective trial on elective lateral neck dissection vs type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas.

Authors: 
Journal:  Head Neck       Date:  1999-12       Impact factor: 3.147

5.  Postoperative morbidity after different types of selective neck dissection.

Authors:  Afshin Teymoortash; Stephan Hoch; Behfar Eivazi; Jochen Alfred Werner
Journal:  Laryngoscope       Date:  2010-05       Impact factor: 3.325

6.  The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients.

Authors:  J A Woolgar
Journal:  Int J Oral Maxillofac Surg       Date:  2007-01-18       Impact factor: 2.789

7.  Therapeutic selective neck dissection outcomes.

Authors:  Peter M Shepard; Jordan Olson; Paul M Harari; Glen Leverson; Gregory K Hartig
Journal:  Otolaryngol Head Neck Surg       Date:  2010-03-20       Impact factor: 3.497

Review 8.  Dissection of the submuscular recess (sublevel IIb) in squamous cell cancer of the upper aerodigestive tract: prospective study and systematic review of the literature.

Authors:  Vinidh Paleri; Selva Kumar Subramaniam; Nashreen Oozeer; Guy Rees; Suren Krishnan
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

9.  Nodal metastases at level IIb during neck dissection for head and neck cancer: clinical and pathologic evaluation.

Authors:  Roberto Santoro; Alessandro Franchi; Oreste Gallo; Giulia Burali; Enrico de' Campora
Journal:  Head Neck       Date:  2008-11       Impact factor: 3.147

Review 10.  Use of decision analysis in planning a management strategy for the stage N0 neck.

Authors:  M H Weiss; L B Harrison; R S Isaacs
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-07
View more
  6 in total

1.  [Follow-up ultrasound of head and neck cancer].

Authors:  J Künzel; A Bozzato; S Strieth
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

2.  pN status predicts outcomes in surgically treated pT1-pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study.

Authors:  Xu Qian; Branko Sinikovic; Frank Schreiber; Sebastian Ochsenreither; Konrad Klinghammer; Barbara Wollenberg; Andreas M Kaufmann; Andreas E Albers
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-29       Impact factor: 2.503

3.  Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Authors:  Janice L Farlow; Andrew C Birkeland; Andrew J Rosko; Kyle VanKoevering; Catherine T Haring; Joshua D Smith; J Chad Brenner; Andrew G Shuman; Steven B Chinn; Chaz L Stucken; Kelly M Malloy; Jeffrey S Moyer; Keith A Casper; Scott A McLean; Mark E P Prince; Carol R Bradford; Gregory T Wolf; Douglas B Chepeha; Matthew E Spector
Journal:  Ann Surg Oncol       Date:  2019-03-04       Impact factor: 5.344

4.  Neck dissection for oral squamous cell carcinoma: our experience and a review of the literature.

Authors:  Pooja Rani; Yogesh Bhardwaj; Praveen Kumar Dass; Manoj Gupta; Divye Malhotra; Narottam Kumar Ghezta
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-12-17

Review 5.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

6.  Efficacy of Superselective Neck Dissection in Detecting Metastasis in Patients with cN0 Papillary Thyroid Carcinoma at High Risk of Lateral Neck Metastasis.

Authors:  Changming An; Xiwei Zhang; Shixu Wang; Zongmin Zhang; Yulin Yin; Zhengang Xu; Pingzhang Tang; Zhengjiang Li
Journal:  Med Sci Monit       Date:  2017-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.